Researchers identified patients with stage I-III TNBC diagnosed between 2010 and 2021 and assessed trends in NACT use, ...
Lantern Pharma Inc. , a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback